Table 2.
BPH | Gleason = 6 | Gleason = 7 | Gleason > 7 | P | |
---|---|---|---|---|---|
SPA (IU) | 1939 (1242–2722) | 1872 (445–3244) | 1548(864–2619) | 1905(1512–2385) | 0.330 |
PSA (ng/ml) | 6.2(3.28–40.3) | 9.3(6.6–38.0) | 13.4(5.1–116.8) | 55.3(6.4–390.8) | 0.001a |
MDA (nmol/ml) | 36.76(21.2–56.8) | 42.1(26.7–146.2) | 38.7(25.1–53.0) | 46.4(36.7–59.9) | 0.078 |
SOD (u/ml) | 19.43 (1.50–278.4) | 37.3(3.1–84.4) | 49.0(8.2–104.3) | 39.2 (7.3–110.7) | 0.647 |
Data were given as median (min-max), SPA Serum prolidase activity, PSA Prostate specific antigen, MDA Malondialdehyde, SOD Superoxide dismutase
astatistical significance